Physician

Sang Hoon Kim, M.D.

According to 2025 Medicare claims, Sang Kim, M.D. (NPI: 1033119417) practices ophthalmology in the Indianapolis-Carmel-Greenwood, IN market, with the plurality of this provider's patient population coming from Marion, IN. This provider's primary affiliated billing organization is RETINA INSTITUTE, P.C. (NPI: 1912911827; TIN: 351992680) and primary practice location at 46227-0989.

Kim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 720 traditional Medicare patients, billed 12,463 HCPCS/CPT codes, and received $926,338 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 1,741 prescription claims across 391 beneficiaries totaling $83,335 in drug costs, led by Brimonidine Tartrate-Timolol (Brimonidine Tartrate/Timolol). Open Payments data shows 12 records totaling $477. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$526K$1.1M2015 Medicare payment: $778,140 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $780,882 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $806,191 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $991,556 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $933,132 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,018,389 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,051,984 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $896,057 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $800,009 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $926,338 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,02010,273$778,140
201699810,088$780,882
20179168,282$806,191
20188967,211$991,556
20198947,210$933,132
20208348,019$1,018,389
20218247,246$1,051,984
20228106,901$896,057
20237397,591$800,009
202472012,463$926,338

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$47K$94K2015 Drug cost: $75,208 (USD; Tot_Drug_Cst)2016 Drug cost: $80,944 (USD; Tot_Drug_Cst)2017 Drug cost: $84,403 (USD; Tot_Drug_Cst)2018 Drug cost: $89,167 (USD; Tot_Drug_Cst)2019 Drug cost: $83,164 (USD; Tot_Drug_Cst)2020 Drug cost: $67,354 (USD; Tot_Drug_Cst)2021 Drug cost: $74,084 (USD; Tot_Drug_Cst)2022 Drug cost: $94,483 (USD; Tot_Drug_Cst)2023 Drug cost: $84,792 (USD; Tot_Drug_Cst)2024 Drug cost: $83,335 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015182765$75,208
2016155716$80,944
2017166820$84,403
2018170849$89,167
2019182884$83,164
2020176826$67,354
2021225989$74,084
20223171,386$94,483
20233391,462$84,792
20243911,741$83,335

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg111640$660
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more242522$93
67028Injection of drug into eye196588$85
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more6411,559$63
92134Imaging of retina5181,929$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol745,043$17,036
Dorzolamide HclDorzolamide Hcl95456,208$16,272
LumiganBimatoprost241,865$12,671
Prednisolone AcetatePrednisolone Acetate1365,418$6,524
Ketorolac TromethamineKetorolac Tromethamine1455,971$5,010

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$477Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sang Hoon Kim, M.D.?

Tedicare shows public-source Medicare data for Sang Hoon Kim, M.D. (NPI 1033119417), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sang Hoon Kim, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sang Hoon Kim, M.D.?

Sang Hoon Kim, M.D. is linked to RETINA INSTITUTE, P.C. (billing NPI 1912911827) in the available physician profile data.

Does Sang Hoon Kim, M.D. have Open Payments data?

Sang Hoon Kim, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.